SNS 공유

팝업닫기

SNS 공유

팝업닫기

논문업적

  1. HOME
  2. KCSG 연구지원
  3. 논문업적

등록된 논문 197

※ 클릭시 해당 논문페이지로 이동합니다.

  • KCSG GU25-01비뇨기암

    Efficacy and safety of cabozantinib plus nivolumab in advanced non-clear cell renal cell carcinoma: a nationwide multicenter study

    • 저널 Oncoimmunology. 2026 Dec 31;15(1):2694175.
    • 제1저자 김창곤, 김준규
    • 교신저자 이재련, 신상준
  • KCSG LY22-15림프종

    Clinico-Pathologic Features of Adult Erdheim?Chester Disease in South Korea: A Multicenter Retrospective Study (KCSG LY22-15)

    • 저널 Cancer Res Treat. 2026 Jun 29.
    • 제1저자 이지윤, 고현정
    • 교신저자 전윤경, 김태민
  • KCSG PC21-19완화의료

    Perceptions and Use of Complementary and Alternative Medicine among Patients with Cancer and Their Family Members (KCSG PC21-19)

    • 저널 Cancer Res Treat. 2026 Jun 11.
    • 제1저자 원영웅, 라선영
    • 교신저자 권정혜
  • KCSG CO24-03대장암

    The Role of Adjuvant Chemotherapy in High-Risk Stage II Colon Cancer with Microsatellite Instability-High or DNA Mismatch Repair Deficiencies: A Multicenter Pooled Analysis (KCSG-CO24-03)

    • 저널 Cancer Res Treat. 2026 May 29.
    • 제1저자 허준영
    • 교신저자 허준영
  • KCSG BR15-01유방암

    A randomized phase III trial of anthracyclines followed by taxane versus taxane plus carboplatin as (neo)adjuvant therapy in patients with triple-negative breast cancer: KCSG BR 15-1 PEARLY trial

    • 저널 Ann Oncol. 2026 May 30:S0923-7534(26)00887-2. Online ahead of print.
    • 제1저자 김건민
    • 교신저자 손주혁
  • KCSG LU21-11폐암

    Lazertinib with stereotactic body radiotherapy in oligometastatic EGFR-mutant non-small-cell lung cancer

    • 저널 ESMO Open. 2026 Feb;11(2):106057
    • 제1저자 이기쁨, 김경환
    • 교신저자 윤홍인, 임선민
  • KCSG CO21-04대장암

    A phase II study of alpelisib and capecitabine in patients with previously treated metastatic colorectal cancer (KCSG-CO21-04)

    • 저널 Sci Rep. 2026 Jun 29. Online ahead of print.
    • 제1저자 임아름
    • 교신저자 이수현
  • KCSG LU21-16폐암

    Lazertinib for Patients with NSCLC Harboring Uncommon EGFR Mutations: A Phase II Multicenter
    Trial

    • 저널 J Thorac Oncol. 2025 Sep;20(9):1279-1288.
    • 제1저자 박세훈
    • 교신저자 홍민희
  • KCSG HN19-09두경부식도암

    Randomized Phase II Trial of Consolidation Pembrolizumab After Definitive Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma: KCSG HN19-09, CONPELAN Study

    • 저널 Head Neck. 2026 May 21.
    • 제1저자 전상훈
    • 교신저자 김범석
  • KCSG CO14-03대장암

    Consolidation Chemotherapy After Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer: 7-Year Follow-Up Results of a Randomized Multicenter Trial (KCSG CO 14-03)

    • 저널 Int J Radiat Oncol Biol Phys. 2026 Jan 16:S0360-3016(26)00080-5.
    • 제1저자 김소진
    • 교신저자 김선영

맨앞으로앞으로12345뒤로맨뒤로

뒤로
뒤로

홈

임상연구
임상연구

교육
교육